Use of melanin biosynthesis inhibitors from korean ginseng and the cosmetic composition containing thereof for skin whitening
US8647610B2 · kind B2 · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2007 |
| Grant date | Feb 11, 2014 |
| Priority date | — |
| Expiry date | Apr 19, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a whitening cosmetic composition containing plant-derived ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) as an active ingredient. More specifically, the ginsenoside F1 is obtained from particularly a ginseng extract using an acid, a base, an enzyme or microorganism, and a whitening cosmetic composition containing the ginsenoside F1 has an excellent effect of inhibiting melanin biosynthesis, and thus provides an excellent skin whitening effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.